Celyad Oncology SA (EBR:CYAD)
Belgium · Delayed Price · Currency is EUR 0.1715
-0.0135 (-7.30%)
Feb 10, 2026, 10:36 AM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €8.28 million as of February 10, 2026. Its market cap has decreased by -55.53% in one year.
Market Cap
8.28M
Enterprise Value
8.32M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.17
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 8.28M, a decrease of -91.88%. That is a compound annual growth rate of -18.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 8.28M | 8.82% |
| Dec 31, 2025 | 7.61M | -74.20% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 49.78B |
| argenx SE | 42.57B |
| Financière de Tubize | 10.02B |
| Hyloris Pharmaceuticals | 207.20M |
| Onward Medical | 183.88M |
| European Medical Solutions | 22.51M |
| BioSenic | 1.50M |
| Oxurion NV | 490.69K |